LeMaitre George W. - 26 Feb 2026 Form 4 Insider Report for LEMAITRE VASCULAR INC (LMAT)

Role
Chairman and CEO, Director
Signature
/s/ Laurie A. Churchill, Attorney-in-fact
Issuer symbol
LMAT
Transactions as of
26 Feb 2026
Net transactions value
-$22,099,765
Form type
4
Filing time
02 Mar 2026, 20:44:43 UTC
Previous filing
15 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
LeMaitre George W Chairman and CEO, Director C/O LEMAITRE VASCULAR, INC., 63 SECOND AVENUE, BURLINGTON /s/ Laurie A. Churchill, Attorney-in-fact 02 Mar 2026 0001365737

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LMAT Common Stock Sale $16,013,355 -150,000 -8.9% $106.76 1,532,304 26 Feb 2026 Direct F1, F2
transaction LMAT Common Stock Award $0 +5,609 +0.37% $0.000000 1,537,913 26 Feb 2026 Direct F3
transaction LMAT Common Stock Options Exercise $0 +13 +0% $0.000000 1,537,926 26 Feb 2026 Direct F4
transaction LMAT Common Stock Tax liability $56,390 -496 -0.03% $113.69 1,537,430 26 Feb 2026 Direct F5
transaction LMAT Common Stock Gift $0 -5,000 -0.33% $0.000000 1,532,430 02 Mar 2026 Direct
transaction LMAT Common Stock Sale $6,030,020 -55,930 -3.6% $107.81 1,476,500 02 Mar 2026 Direct F6
holding LMAT Common Stock 33,400 26 Feb 2026 LEMAITRE IRREVOCABLE LIFE INSURANCE TRUST OF 2025 F7

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LMAT Dividend Equivalent Rights Options Exercise $0 -13 -28% $0.000000 33 26 Feb 2026 Common Stock 13 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Sold pursuant to a 10b5-1(c) plan adopted 03-10-2025.
F2 The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $103.05 to $113.50. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
F3 These shares represent LMAT common stock acquired on February 26, 2026, upon settlement of a Performance Share Unit (PSU) award granted on December 6, 2024. The PSU award vested 25% upon determination of satisfaction of the performance condition (on 2/26/2026), and the balance vests in equal annual installments on the grant date anniversary over the next three years.
F4 Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.
F5 These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of PSUs awarded to the reporting person on December 6, 2024. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.
F6 The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $106.95 to $109.49. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
F7 These shares are held by an irrevocable trust for the benefit of Reporting Person's child(ren). The Reporting Person disclaims ownership of such securities except to the extent of his pecuniary interest therein, if any, and the reporting herein of such securities shall not be construed as an admission of beneficial ownership thereof for the purposes of Section 16 or for any other purpose.
F8 These dividend equivalent rights were released in connection with the vesting of a PSU award granted on December 6, 2024. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.